Evan M Hersh

Research output

Research output per year 1965 2018

• 19618 Citations
• 67 h-Index
• 500 Article
• 24 Review article
• 12 Letter
• 3 Comment/debate
• 2 More
  • 1 Conference contribution
  • 1 Editorial

Research output per year

Research output per year

Search results

• Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-γ and tumor necrosis factor-α¹

  Chong, A. S. F., Pinkard, J. K., Lam, K. S., Scuderi, P., Hersh, E. M. & Grimes, W. J., Apr 15 1991, In: Cellular Immunology. 134, 1, p. 96-110 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphokine-Activated Killer Cells
  • Interferons
  • Membrane Proteins
  • Tumor Necrosis Factor-alpha
  • Neoplasms
  1 Scopus citations

• Abnormal lymphocyte response to exogenous interleukin-2 in homosexuals with acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC)

  Murray, J. L., Hersh, E. M., Reuben, J. M., Munn, C. G. & Mansell, P. W., 1985, In: Clinical and Experimental Immunology. 60, 1, p. 25-30 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Sexual and Gender Minorities
  • Interleukin-2
  • Acquired Immunodeficiency Syndrome
  • Lymphocytes
  • Prodromal Symptoms
  20 Scopus citations

• Acquired immune deficiency syndrome: A new clinical entity

  Hersh, E. M. & Mansell, P. W. A., Apr 1 1983, In: Clinical Immunology Newsletter. 4, 4, p. 39-43 5 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• Actinomycin‐D plus 5‐(3,3‐dimethyl‐ 1‐triazeno)‐ imidazole‐4‐carboxamine (DTIC) with or without intravenous corynebacterium parvum in metastatic malignant melanoma

  Robidoux, A., Gutterman, J. U., Bodey, G. P. & Hersh, E. M., Jun 1 1982, In: Cancer. 49, 11, p. 2246-2251 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Propionibacterium acnes
  • Dacarbazine
  • Melanoma
  • Drug Therapy
  • Body Surface Area
  7 Scopus citations

• Activation of Cyclic Nucleotide Phosphodiesterase from Isolated Human Peripheral Blood Lymphocytes by Mitogenic Agents

  Epstein, P. M., Mills, J. S., Hersh, E. M., Strada, S. J. & Thompson, W. J., Feb 1 1980, In: Cancer Research. 40, 2, p. 379-386 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Cyclic Nucleotides
  • Phosphoric Diester Hydrolases
  • Phytohemagglutinins
  • Lymphocytes
  • Cyclic AMP
  29 Scopus citations

• Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine

  Thompson, W. J., Ross, C. P., Hersh, E. M., Epstein, P. M. & Strada, S. J., Jun 13 1980, In: Journal of Cyclic Nucleotide Research. 6, 1, p. 25-36 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphocytes
  • 1-Methyl-3-isobutylxanthine
  • Cell culture
  • Phosphoric Diester Hydrolases
  • Lymphocyte Activation
  8 Scopus citations

• ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA

  Gutterman, J. U., McBride, C., Freireich, E. J., Mavligit, G., Frei, E. & Hersh, E. M., Jun 2 1973, In: The Lancet. 301, 7814, p. 1208-1212 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Active Immunotherapy
  • Mycobacterium bovis
  • Melanoma
  • Immunotherapy
  • Delayed Hypersensitivity
  189 Scopus citations

• Active specific immunization in malignant melanoma

  Gercovich, F. G., Gutterman, J. U., Maviigit, G. M. & Hersh, E. M., 1975, In: Medical and Pediatric Oncology. 1, 3, p. 277-287 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Melanoma
  • Vaccination
  • Immunization
  • Neoplasms
  • Mycobacterium bovis
  5 Scopus citations

• Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia

  Ezaki, K., Hersh, E. M., Keating, M., Hollinshead, S. D. A., McCredie, K. B., Mavlight, G. M. & Gutterman, J. U., Jan 1978, In: Cancer. 41, 1, p. 70-83 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Allogeneic Cells
  • Leukemia
  • Vaccination
  • Antigens
  • Immunization
  8 Scopus citations

• Acute leukemia in adults, 1977

  Keating, M. J., Freireich, E. J., McCredie, K. B., Bodey, G. P., Hersh, E., Hester, J. P., Rodriguez, V. & Hart, J., 1977, In: CA: A Cancer Journal for Clinicians. 27, 1, p. 2-25 24 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED)

  Buzdar, A. U., Blumenschein, G. R., Smith, T. L., Tashima, C. K., Hortobagyi, G. N., Yap, H. Y., Gutterman, J. U., Hersh, E. M. & Gehan, E. A., 1979, In: Journal of Surgical Oncology. 12, 1, p. 27-40 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Neoplasms
  • Recurrence
  • Mycobacterium bovis
  • Cyclophosphamide
  • Doxorubicin
  44 Scopus citations

• Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette‐Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

  Buzdar, A. U., Blumenschein, G. R., Smith, T. L., Powell, K. C., Hortobagyi, G. N., Yap, H. Y., Schell, F. C., Barnes, B. C., Ames, F. C., Martin, R. G. & Hersh, E. M., Feb 1 1984, In: Cancer. 53, 3, p. 384-389 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Adjuvant Chemotherapy
  • Bacillus
  • Fluorouracil
  • Cyclophosphamide
  • Doxorubicin
  59 Scopus citations

• Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C). Prolongation of disease‐free interval and survival

  Mavligit, G. M., Gutterman, J. U., Malahy, M. A., Burgess, M. A., McBride, C. M., Jubert, A. & Hersh, E. M., Nov 1977, In: Cancer. 40, 5 S, p. 2726-2730 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Mycobacterium bovis
  • Immunotherapy
  • Colorectal Neoplasms
  • Survival
  • Fluorouracil
  25 Scopus citations

• Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results

  Mavligit, G. M., Gutterman, J. U., Burgess, M. A., Khankhanian, N., Seibert, G. B., Speer, J. F., Reed, R. C., Jubert, A. V., Martin, R. C., McBride, C. M., Copeland, E. M., Gehan, E. A. & Hersh, E. M., Dec 1975, In: Cancer. 36, 6 S, p. 2421-2427 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Mycobacterium bovis
  • Immunotherapy
  • Colorectal Neoplasms
  • Recurrence
  • Survival
  21 Scopus citations

• Administration of BCG cell wall skeleton into malignant effusions: Toxic and therapeutic effects

  Richman, S. P., Hersh, E. M., Gutterman, J. U., Hortobagyi, G. N., Blumenschein, G. R., Rios, A. & Ribi, E., Aug 29 1981, In: Cancer Treatment Reports. 65, 5-6, p. 383-387 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cell Wall Skeleton
  • Mycobacterium bovis
  • Ascitic Fluid
  • Therapeutic Uses
  • Vaccines
  8 Scopus citations

• Advances in the biological therapy and gene therapy of malignant disease

  Hersh, E. M. & Stopeck, A. T., Dec 1 1997, In: Clinical Cancer Research. 3, 12 II, p. 2623-2629 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Biological Therapy
  • Genetic Therapy
  • Neoplasms
  • HLA-B7 Antigen
  • Factor X
  30 Scopus citations

• A four‐year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia

  Keating, M. J., Smith, T. L., McCredie, K. B., Bodey, G. P., Hersh, E. M., Gutterman, J. U., Gehan, E. & Freireich, E. J., Jun 15 1981, In: Cancer. 47, 12, p. 2779-2788 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Anthracyclines
  • Cytarabine
  • Vincristine
  • Prednisone
  • Combination Drug Therapy
  87 Scopus citations

• A Human Monoclonal Antimelanoma Single-Chain Fv Antibody Derived from Tumor-infiltrating Lymphocytes

  Zhang, H., Lake, D. F., Barbuto, J. A. M., Bernstein, R. M., Grimes, W. J. & Hersh, E. M., Aug 1 1995, In: Cancer Research. 55, 16, p. 3584-3591 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Single-Chain Antibodies
  • Tumor-Infiltrating Lymphocytes
  • B-Lymphocytes
  • Melanoma
  • Polymerase Chain Reaction
  30 Scopus citations

• A hybridoma producing human monoclonal antibody specific for glycoprotein 120kDa of human immunodeficiency virus (HIV-1)

  Lake, D., Sugano, T., Matsumoto, Y. I., Masuho, Y., Petersen, E. A., Feorino, P. & M. Hersh, E., 1989, In: Life Sciences. 45, 16, p. iii-x

  Research output: Contribution to journal › Article › peer-review

  • Viruses
  • Hybridomas
  • HIV-1
  • Glycoproteins
  • Lymphocytes
  6 Scopus citations

• Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

  Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M. & Gutterman, J. U., Jan 5 1984, In: New England Journal of Medicine. 310, 1, p. 15-18 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Hairy Cell Leukemia
  • Remission Induction
  • Interferon-alpha
  • Agranulocytosis
  • Thrombocytopenia
  686 Scopus citations

• Alternating noncross‐resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER‐BCG for advanced breast carcinoma

  Blumenschein, G. R., Hortobagyi, G. N., Richman, S. P., Gutterman, J. U., Tashima, C. K., Buzdar, A. U., Burgess, M. A., Livingston, R. B. & Hersh, E. M., Feb 15 1980, In: Cancer. 45, 4, p. 742-749 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Active Immunotherapy
  • Mycobacterium bovis
  • Combination Drug Therapy
  • CAF protocol
  • Breast Neoplasms
  23 Scopus citations

• Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon

  Lotzova, E., Savary, C. A., Quesada, J. R., Gutterman, J. U. & Hersh, E. M., Dec 1 1983, In: Journal of the National Cancer Institute. 71, 5, p. 903-910 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Natural Killer Cells
  • Interferons
  • Neoplasms
  • Injections
  • Phenotype
  23 Scopus citations

• Analysis of the Antitumor Agent Bay i 7433 (Copovithane) in Plasma and Urine by High Performance Liquid Chromatography

  Rosenblum, M. G., Hersh, E. M. & Wingender, W., Jan 1 1984, In: Journal of Liquid Chromatography. 7, 1, p. 159-166 8 p.

  Research output: Contribution to journal › Article › peer-review

  • copovithane
  • High performance liquid chromatography
  • methylamine
  • Antineoplastic Agents
  • Plasmas
  2 Scopus citations

• An effective new chemoimmunotherapy regimen for disseminated malignant melanoma (DMM)

  Gutterman, J., Hersh, E. & Benjamin, R., Jan 1 1977, In: Proceedings of the American Association for Cancer Research. vol. 18, p. No. C-135

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A new type of synthetic peptide library for identifying ligand-binding activity

  Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierskit, W. M. & Knappt, R. J., Nov 7 1991, In: Nature. 354, 6348, p. 82-84 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Peptide Library
  • Ligands
  • Libraries
  • Oligodeoxyribonucleotides
  • Cell Surface Receptors
  1645 Scopus citations

• An in vivo model of human multidrug-resistant multiple myeloma in SCID mice

  Bellamy, W. T., Odeleye, A., Finley, P., Huizenga, B., Dalton, W. S., Weinstein, R. S., Hersh, E. M. & Grogan, T. M., 1993, In: American Journal of Pathology. 142, 3, p. 691-698 8 p.

  Research output: Contribution to journal › Article › peer-review

  • SCID Mice
  • Multiple Myeloma
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Heterografts
  • Doxorubicin
  29 Scopus citations

• Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients

  Minden, P., Jarrett, C., Mcclatchy, J. K., Gutterman, J. U. & Hersh, E. M., Dec 1 1976, In: Nature. 263, 5580, p. 774-777 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Mycobacterium bovis
  • Melanoma
  • Antigens
  • Antibodies
  • Mycobacterium
  20 Scopus citations

• Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro

  Robinson, W. E., Kawamura, T., Lake, D., Masuho, Y., Mitchell, W. M. & Hersh, E. M., 1990, In: Journal of virology. 64, 11, p. 5301-5305 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunodominant Epitopes
  • Human immunodeficiency virus 1
  • HIV-1
  • Glycoproteins
  • glycoproteins
  91 Scopus citations

• Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction

  Barbuto, J. A. M., Grimes, W. J. & Hersh, E. M., Jan 1 1995, In: Cancer Immunology Immunotherapy. 40, 1, p. 31-36 6 p.

  Research output: Contribution to journal › Article › peer-review

  • B-Lymphocytes
  • Tumor Necrosis Factor-alpha
  • Antibodies
  • Antibody Formation
  • Neoplasms
  8 Scopus citations

• Antibody‐dependent cell‐mediated cytotoxicity in human cancer: Characterization of patient leukocyte activity and treatment effects

  Hersh, E. M., Murphy, S. G., Gutterman, J. U., Morgan, J., Quesada, J., Zander, A. & Stewart, D., Jan 15 1982, In: Cancer. 49, 2, p. 251-260 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukocytes
  • Erythrocytes
  • Hairy Cell Leukemia
  • Propionibacterium acnes
  • Isoantibodies
  22 Scopus citations

• Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells

  Savage, H. E., Rossen, R. D., Hersh, E. M., Freedman, R. S., Bowen, J. M. & Plager, C., Apr 1 1986, In: Cancer Research. 46, p. 2127-2133 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Oncogenic Viruses
  • Allogeneic Cells
  • Melanoma
  • Carcinoma
  • Antigens
  28 Scopus citations

• Antibody responses of leukemia patients in remission who receive active specific immunotherapy

  Granatek, C., Ezaki, K. & Hersh, E., 1979, In: Proceedings of the American Association for Cancer Research. Vol. 20, p. No. 684

  Research output: Contribution to journal › Article › peer-review

• Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy

  Granatek, C. H., Ezaki, K., Hersh, E. M., Keating, M. J. & Rasmussen, S., Jan 15 1981, In: Cancer. 47, 2, p. 272-279 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Antibody Formation
  • Immunotherapy
  • Leukemia
  • Mycobacterium bovis
  • Antigens
  9 Scopus citations

• Antigen dose in the human immune response. Dose-response relationships in the human immune response to Keyhole limpet hemocyanin

  Curtis, J. E., Hersh, E. M., Butler, W. T. & Rossen, R. D., Jul 1971, In: The Journal of Laboratory and Clinical Medicine. 78, 1, p. 61-69 9 p.

  Research output: Contribution to journal › Article › peer-review

  • keyhole-limpet hemocyanin
  • Antigens
  • Lymphocytes
  • Immunization
  • Hemagglutinins
  27 Scopus citations

• Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast

  Coronella, J. A., Spier, C., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H. & Hersh, E. M., Aug 15 2002, In: Journal of Immunology. 169, 4, p. 1829-1836 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Carcinoma, Ductal, Breast
  • B-Lymphocytes
  • Antigens
  • Neoplasms
  • Ductal Carcinoma
  113 Scopus citations

• ANTIGEN EXPRESSION AND CELL SURFACE PROPERTIES OF HUMAN LEUKEMIC BLASTS

  Cotropia, J. P., Gutterman, J. U., Hersh, E. M., Granatek, C. H. & Mavligit, G. M., Sep 1976, In: Annals of the New York Academy of Sciences. 276, 1, p. 146-164 19 p.

  Research output: Contribution to journal › Article › peer-review

  • Surface Properties
  • Surface properties
  • Immunoglobulin G
  • Immunoglobulin Fab Fragments
  • Cells
  8 Scopus citations

• Antigen solubilized from human leukemia: Lymphocyte stimulation

  Gutterman, J. U., Mavligit, G., McCredie, K. B., Bodey, G. P., Freireich, E. J. & Hersh, E. M., Jan 1 1972, In: Science. 177, 4054, p. 1114-1115 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphocyte Activation
  • Leukemia
  • Lymphocytes
  • Antigens
  • Tissue Donors
  49 Scopus citations

• Antigen-specific Immunity in Recipients of Leukocyte Transfusions from Immune Donors

  Curtis, J. E., Hersh, E. M. & Freireich, E. J., Dec 1970, In: Cancer Research. 30, 12, p. 2921-2929 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukocyte Transfusion
  • keyhole-limpet hemocyanin
  • Alanine
  • Lysine
  • Tyrosine
  9 Scopus citations

• Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro

  Hersh, E. M., Gschwind, C. R., Taylor, C. W., Dorr, R. T., Taetle, R. & Salmon, S. E., Aug 19 1992, In: Journal of the National Cancer Institute. 84, 16, p. 1238-1244 7 p.

  Research output: Contribution to journal › Article › peer-review

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one
  • Tumor Cell Line
  • In Vitro Techniques
  • Neoplasms
  • Lymphoma
  33 Scopus citations

• Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes

  Punt, C. J. A., Barbuto, J. A. M., Zhang, H., Grimes, W. J., Hatch, K. D. & Hersh, E. M., Jul 1 1994, In: Cancer Immunology Immunotherapy. 38, 4, p. 225-232 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Neoplasm Antibodies
  • Anti-Idiotypic Antibodies
  • B-Lymphocytes
  • Feeder Cells
  • Neoplasms
  44 Scopus citations

• A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma

  Weber, J. S., Samlowski, W. E., Gonzalez, R., Ribas, A., Stephenson, J., O'Day, S., Sato, T., Dorr, R., Grenier, K. & Hersh, E., Aug 1 2010, In: Cancer. 116, 15, p. 3683-3691 9 p.

  Research output: Contribution to journal › Article › peer-review

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one
  • Dacarbazine
  • Melanoma
  • Maximum Tolerated Dose
  • aziridine
  16 Scopus citations

• A phase 2 clinical trial of nab-Paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma

  Hersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A. A. & Gonzalez, R., Jan 1 2010, In: Cancer. 116, 1, p. 155-163 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Albumin-Bound Paclitaxel
  • Melanoma
  • Clinical Trials
  • Drug Therapy
  • Survival
  97 Scopus citations

• A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

  Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E., Jan 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.

  Research output: Contribution to journal › Article › peer-review

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one
  • gemcitabine
  • Multicenter Studies
  • Adenocarcinoma
  • Placebos
  3 Scopus citations

• A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

  Taylor, C. W., Dorr, R. T., Fanta, P., Hersh, E. M. & Salmon, S. E., 2001, In: Cancer Chemotherapy And Pharmacology. 47, 1, p. 83-88 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pharmacodynamics
  • Asparaginase
  • Polyethylene Glycols
  • Tumors
  • Asparagine
  41 Scopus citations

• A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

  Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 2011, In: Investigational New Drugs. 29, 3, p. 489-498 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Ipilimumab
  • Dacarbazine
  • Multicenter Studies
  • Melanoma
  • Drug Therapy
  226 Scopus citations

• A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A southwest oncology group study

  Brown, T. D., Goodman, P., Fleming, T., Macdonald, J. S., Hersh, E. M. & Braun, T. J., Oct 1991, In: Journal of Immunotherapy. 10, 5, p. 376-378 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Pancreas
  • Adenocarcinoma
  • Tumor Necrosis Factor-alpha
  • Hypertriglyceridemia
  • Anorexia
  31 Scopus citations

• A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: A southwest oncology group study

  Whitehead, R. P., Fleming, T., Macdonald, J. S., Goodman, P. J., Neefe, J., Braun, T. J., Swinnen, L. J. & Hersh, E. M., Dec 1990, In: Journal of Biological Response Modifiers. 9, 6, p. 588-591 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Adenocarcinoma
  • Tumor Necrosis Factor-alpha
  • Nausea
  • Vomiting
  • Subclavian Vein
  22 Scopus citations

• A Phase II Trial of Vinorelbine Tartrate in Patients with Disseminated Malignant Melanoma and One Prior Systemic Therapy: A Southwest Oncology Group Study

  Whitehead, R. P., Moon, J., McCachren, S. S., Hersh, E. M., Samlowski, W. E., Beck, J. T., Tchekmedyian, N. S. & Sondak, V. K., Apr 15 2004, In: Cancer. 100, 8, p. 1699-1704 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Vinorelbine
  • Melanoma
  • Therapeutics
  • Progression-Free Survival
  • Confidence Intervals
  18 Scopus citations

• A phase i study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

  Cohen, S. J., Zalupski, M. M., Modiano, M. R., Conkling, P., Patt, Y. Z., Davis, P., Dorr, R. T., Boytim, M. L. & Hersh, E. M., Jul 2010, In: Cancer Chemotherapy And Pharmacology. 66, 2, p. 287-294 8 p.

  Research output: Contribution to journal › Article › peer-review

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one
  • gemcitabine
  • Pancreatic Neoplasms
  • Toxicity
  • Maximum Tolerated Dose
  19 Scopus citations

• A phase I study of intravenous azimexon therapy in human cancer

  Patt, Y. Z., Hersh, E. M., Reuben, J., Claghorn, L. & Mavligit, G., Aug 1986, In: Journal of Biological Response Modifiers. 5, 4, p. 313-318 6 p.

  Research output: Contribution to journal › Article › peer-review

  • azimexon
  • Cell Count
  • Lymphocyte Count
  • Muromonab-CD3
  • Neoplasms
  5 Scopus citations